Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women.
about
Rapid point of care test for detecting urogenital Chlamydia trachomatis infection in nonpregnant women and men at reproductive ageA randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the "TTANGO" trial protocol.Evaluating the utility of syndromic case management for three sexually transmitted infections in women visiting hospitals in Delhi, IndiaPoint-of-care test for detection of urogenital chlamydia in women shows low sensitivity. A performance evaluation study in two clinics in Suriname.Canadian Public Health Laboratory Network laboratory guidelines for the use of point-of-care tests for the diagnosis of syphilis in Canada.Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challengesChlamydia and gonorrhoea in pregnancy: effectiveness of diagnosis and treatment in BotswanaPublic health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative studyChlamydia trachomatis load at matched anatomic sites: implications for screening strategies.New point of care Chlamydia Rapid Test--bridging the gap between diagnosis and treatment: performance evaluation study.Prevalence of Chlamydia trachomatis infection among low- and high-risk Filipino women and performance of Chlamydia rapid tests in resource-limited settings.Rapid tests for sexually transmitted infections (STIs): the way forwardApplications of molecular testing in clinical laboratories for the diagnosis and control of gonorrhea.Modelling the cost effectiveness of rapid point of care diagnostic tests for the control of HIV and other sexually transmitted infections among female sex workersWhat is the achievable effectiveness of the India AIDS Initiative intervention among female sex workers under target coverage? Model projections from southern India.Near-patient testing will improve the control of sexually transmitted infections: the arguments in favourNear-patient testing will not improve the control of sexually transmitted infections.Testing for sexually transmitted infections: a brave new world?Evaluation of a rapid point-of-care test for the detection of gonococcal infection among female sex workers in Benin.Identification of chlamydia and gonorrhoea among women in rural Haiti: maximising access to treatment in a resource poor setting.Clinic-based evaluation of a rapid point-of-care test for detection of Chlamydia trachomatis in specimens from sex workers in Escuintla, GuatemalaAn early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in EnglandDiagnostic challenges of sexually transmitted infections in resource-limited settings.Identifying a need for more focused treatment of chlamydia and gonorrhoea in the emergency department.Diagnostic accuracy of rapid tests for sexually transmitted infections in symptomatic women.Comparison of two Gram stain point-of-care systems for urogenital gonorrhoea among high-risk patients: diagnostic accuracy and cost-effectiveness before and after changing the screening algorithm at an STI clinic in Amsterdam.Field evaluation of the CRT and ACON chlamydia point-of-care tests in a tropical, low-resource setting.Advances in sampling and screening for chlamydia.Syndromic approach to sexually transmitted infections in Tunisian women: bacteriological validation.Point-of-care tests for the diagnosis of Neisseria gonorrhoeae infection: a systematic review of operational and performance characteristics.Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria gonorrhoeae: a modelling study.Asymptomatic men: should they be tested for urethritis?
P2860
Q24188126-DF39C026-23E0-4D8A-8077-2BED7E8F69F3Q31141987-87816C4F-A358-434D-BBA3-1CA93DD156CEQ33684129-63DCB3FB-2506-47F9-88E4-DEAA469BDCF8Q34185778-AC38F8B1-9740-4D30-A218-6111106B8D3AQ35160261-6A508DD9-A813-448A-9B22-AEF8152AFA4DQ35531267-6C9DBDD1-4826-4D3D-81D5-48187ED8129CQ35531509-22B15628-0FAF-4BF8-B326-1EB6E49C9D28Q35573127-A9C8C96B-64D7-4A13-B4DF-AEA99F332CFAQ35784603-53DF56A1-93EC-4065-8920-EE9212999E19Q36248523-CAACB4F5-21BD-4C51-8458-CE4D4E6BE34DQ36314501-40327C83-732B-434B-85FA-26A6644C3237Q36675814-6451BE49-F580-419B-95F0-7B0D19E960A6Q36895641-B7E7A623-4DC1-4731-8CB8-36BE857DF282Q36928543-0AF7EAB9-504B-433E-9C81-1793E1060473Q36928589-2126810F-4E45-42EA-97E1-956BED52B3FFQ36928612-7293F177-3008-428F-BABB-4EE5C82F942BQ36928666-076550AF-0DD0-4D77-BCFF-CF7CCEC66C81Q36928699-56792451-F018-47A7-BF01-8909D3CDE756Q36928828-E80D2EE8-52F4-4628-8CB0-20E1ABA5074FQ36930419-A0C96693-BF8F-4A78-B962-4B60A93DE0B1Q37099616-F577EE39-F22D-4D64-9479-9F1392431526Q37599522-7D482E7D-C7FA-4E3A-AF65-14D33E2A0AA7Q37648697-96877E6B-17A5-499E-B3DA-6BD12A4C6F16Q37839012-D09E136C-8574-42F3-BFF1-C47DF28F0BDFQ37840023-926EC5A9-698C-4C5D-985A-B1623802564AQ37844307-8D9C8F91-9815-49BE-95ED-A14E7D14E172Q37845345-3531509F-AA24-4A81-90E0-A8C06A37A543Q37846961-751C7670-4C4C-4C10-8BDB-718279DCEA9EQ37857883-8D5D3FF3-5656-4EC4-8AB0-469B8A924A78Q38055133-CFF1D1FB-10A1-4A9D-8FBB-47F8A809C1B5Q39190909-5CF16009-1A0F-4270-8337-B93BBA9CBD87Q41087135-F8ECE1CE-5026-434B-8CD7-C68C463FE5A8
P2860
Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Sensitivity requirements for t ...... eisseria gonorrhoeae in women.
@ast
Sensitivity requirements for t ...... eisseria gonorrhoeae in women.
@en
type
label
Sensitivity requirements for t ...... eisseria gonorrhoeae in women.
@ast
Sensitivity requirements for t ...... eisseria gonorrhoeae in women.
@en
prefLabel
Sensitivity requirements for t ...... eisseria gonorrhoeae in women.
@ast
Sensitivity requirements for t ...... eisseria gonorrhoeae in women.
@en
P2093
P356
P1476
Sensitivity requirements for t ...... Neisseria gonorrhoeae in women
@en
P2093
P304
P356
10.1136/STI.79.5.363
P577
2003-10-01T00:00:00Z